Hyperpigmentation is one of the most common skin concerns and one of the most frustrating to address, because the word covers several different conditions that have different causes and respond differently to treatment. Using the wrong approach for your type of hyperpigmentation wastes time and money. Identifying what you’re actually dealing with is step one.
The three main types
Post-inflammatory hyperpigmentation (PIH) forms after skin injury or inflammation. Acne, cuts, insect bites, or any wound can trigger the melanocytes (pigment-producing cells) in the area to produce excess melanin as part of the healing response. The result is a dark mark that remains after the original lesion has healed. PIH is more common and typically darker in skin with higher natural melanin content.
Sun damage (solar lentigines, commonly called sun spots or age spots) is caused by cumulative UV exposure triggering localised overproduction of melanin in areas that receive the most sun. These appear gradually over years of sun exposure, most commonly on the face, hands, and shoulders. They’re flat, well-defined, and range from light tan to dark brown.
Melasma appears as larger patches of irregular, diffuse pigmentation, typically on the cheeks, forehead, upper lip, and chin. It’s strongly associated with hormonal factors, particularly oestrogen. Pregnancy, oral contraceptive pills, and hormone replacement therapy commonly trigger or worsen melasma. It’s one of the most treatment-resistant forms of hyperpigmentation because the hormonal driver can continue producing pigment as fast as treatments fade it.
Sun protection: the absolute first step
Any discussion of hyperpigmentation treatment has to start here. UV radiation is either the direct cause (sun spots) or a significant aggravating factor for PIH and melasma. Any brightening treatment is working against itself if daily SPF isn’t in place. Melanocytes that have been triggered into overproduction by UV exposure will keep producing pigment regardless of what brightening ingredients you layer on top.
SPF 30 or higher, applied every morning and reapplied after two to three hours of sun exposure, is the foundation. For melasma in particular, this is non-negotiable. Some dermatologists recommend SPF 50 for melasma patients because even partial UV exposure can maintain the condition. Wearing a hat in direct sun adds protection that SPF alone doesn’t fully provide.
Ingredients with good evidence for fading pigmentation
Vitamin C (L-ascorbic acid and stabilised derivatives) inhibits tyrosinase, the enzyme required for melanin synthesis. Multiple clinical studies support its brightening effect at 10-20% concentration with consistent use. It also provides antioxidant protection against UV-induced pigment stimulation. A 2002 study published in the Journal of Drugs in Dermatology confirmed significant improvement in hyperpigmentation with topical vitamin C over 16 weeks.
Alpha-arbutin is a glycosylated hydroquinone that inhibits tyrosinase without the safety concerns associated with hydroquinone itself. At 1-2%, it has solid evidence for brightening and is well-tolerated by most skin types including sensitive skin. It works more slowly than vitamin C but with a better sensitivity profile.
Niacinamide at 5% inhibits the transfer of melanosomes (melanin packets) from melanocytes to keratinocytes, which is a different mechanism from tyrosinase inhibition. This means it’s complementary to vitamin C and arbutin. The combination can be more effective than either alone.
Azelaic acid at 10-20% is one of the few ingredients specifically studied and approved for melasma treatment. It combines tyrosinase inhibition with anti-inflammatory properties. It’s effective, prescription at higher concentrations in many markets, and well-studied across multiple skin types.
Kojic acid, derived from fungal fermentation, is a tyrosinase inhibitor with good brightening evidence. It can be a sensitiser in some people and is less widely available in high-quality stable formulations, but it appears in some effective brightening products.
Exfoliants for pigmentation
AHAs, particularly glycolic acid and lactic acid, work on pigmentation through two mechanisms: accelerating cell turnover to remove pigmented cells from the surface faster, and mildly inhibiting melanin synthesis. Regular use shows cumulative brightening over time. This is not a fast fix, but AHA exfoliation alongside a brightening serum addresses pigmentation more effectively than brightening actives alone.
The combination of a tyrosinase inhibitor (vitamin C, arbutin, niacinamide), regular gentle AHA exfoliation, and daily SPF is the evidence-based approach to hyperpigmentation treatment that dermatologists consistently recommend for all three pigmentation types.
Timeline and expectations
PIH from acne or minor injuries responds to treatment within two to six months with consistent use of appropriate actives and SPF. Fresh PIH (less than six months old) responds faster than older marks. PIH in deeper skin tones takes longer to fade because higher melanin baseline means more pigment to clear.
Sun spots respond similarly but require ongoing SPF to prevent new spots forming while old ones fade. With consistent treatment, most sun spots show meaningful improvement within three to six months.
Melasma is genuinely difficult. The hormonal driver can maintain pigmentation faster than brightening actives can fade it. Some dermatologists use tranexamic acid, both topical and oral, for resistant melasma cases. Laser treatments can be effective but also carry the risk of post-inflammatory hyperpigmentation if not correctly matched to skin tone. Managing the hormonal trigger, where possible, often does more for melasma than topical treatments alone.
What not to do
Don’t use hydroquinone long-term without medical supervision. It’s effective but associated with ochronosis (paradoxical darkening) with prolonged use, particularly in higher skin tones. Most European countries restrict it to prescription use for good reasons.
Don’t try to speed up results by using multiple strong brightening actives simultaneously. This typically increases irritation risk, which can trigger more PIH, making the situation worse. Layer brightening actives thoughtfully rather than combining every option at once.